Royal Sense Limited IPO
RoyalSense emerges as a pivotal supplier in the healthcare sector, specializing in high-quality goods that align with international standards essential for hospitals, laboratories, institutions, and clinics. Their expertise lies in trading and offering an extensive range of surgical accessories, tools, equipment, and more, tailored to meet the diverse needs of healthcare providers.
Comprehensive Product Portfolio
Their offerings encompass a broad spectrum, including medical equipment, surgical instruments, surgical consumables, laboratory equipment, laboratory reagents, medical consumables, diagnostic equipment, sanitary napkins, pharmaceuticals, medicine, and cosmetics. This wide range of parameters ensures that they can accommodate the specific requirements of their clients, making them a one-stop solution for comprehensive healthcare needs.
Expanding Supply Chain and Market Reach
Their operational strategy is geared towards maximizing accessibility and efficiency. They have integrated their supply chain with government e-procurement systems, including tender systems and the GEM Portal, to streamline their distribution process. Their clientele spans across various states such as Uttar Pradesh, Himachal Pradesh, Rajasthan, and Jammu & Kashmir, catering to the Ministry of Health and other governmental and private healthcare institutions across India, either directly or through a network of distributors and sub-distributors.
In conclusion, RoyalSense is not just a supplier; they are a partner in healthcare excellence, committed to enhancing the quality of health services through their extensive range of products and dedicated service. Their strategic positioning and operational excellence ensure that they meet the evolving needs of the healthcare sector, establishing RoyalSense as a trusted name in healthcare supplies.
Objects of the Royal Sense Limited IPO:
Royal Sense Limited IPO Details:
Open Date: | Mar 12 2024 |
Close Date: | Mar 14 2024 |
Total Shares: | 1,450,000 |
Face Value: | ₹ 10 Per Equity Share |
Issue Size: | 9.86 Cr. |
Lot Size: | 2000 Shares |
Issue Price: | ₹ 68 Per Equity Share |
Listing At: | BSE SME |
Listing Date: | Mar 19 2024 |
Promoters And Management:
Financials of Royal Sense Limited IPO:
Particular (In Lakh) | Mar-21 | Mar-22 | Mar-23 |
Revenue from Operations | 713 | 675 | 1,156 |
Purchases | 664 | 603 | 1095 |
Change in Inventory | -7 | 12 | -36 |
Employee Cost | 19 | 10 | 6 |
Other Expenses | 14 | 27 | 25 |
EBITDA | 23 | 23 | 66 |
EBIDTA Margin | 3.23% | 3.41% | 5.71% |
Other income | 0 | 0 | 70 |
Depreciation | 2 | 1 | 0 |
Interest | 0 | 0 | 4 |
Profit before tax | 21 | 22 | 132 |
Tax | 0 | 0 | 0 |
Net profit | 21 | 22 | 132 |
NPM (%) | 2.95% | 3.26% | 10.77% |
Comparison With Peers:
Name of the Companies | Revenue (Cr) | Profit (Cr) | EPS | P/E | CMP | MCap (Cr) |
Royal Sense Limited | 11.5 | 1.3 | 2.65 | 25.6 | 68 | 33 |
Hemant Surgical Industries Limited | 109 | 8 | 413 | 17.7 | 130 | 136 |
Centenial Surgical Suture Ltd | 52 | 0.8 | 2.4 | 36.8 | 99 | 36 |
Recommendation on Royal Sense Limited IPO:
To be updated shortly.
Lead Manager of Royal Sense Limited IPO:
Registrar of Royal Sense Limited IPO:
Company Address:
Discussion on Royal Sense Limited IPO:
Leave a Reply
You must be logged in to post a comment.